All > Multiple Sclerosis > San Francisco

MS FIT: Falls Insight Track for Multiple Sclerosis

University of California, San Francisco, San Francisco, CA
Multiple SclerosisMS FIT: Falls Insight Track - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial aims to develop an app to help MS patients log falls, view health data & communicate with their care team about falls prevention.

Eligible Conditions
  • Multiple Sclerosis

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
Diet Intervention
1
Vancomycin
2
fenebrutinib

Study Objectives

5 Primary · 0 Secondary · Reporting Duration: 12 months

12 months
Percentage of patient-clinician encounters use the tool during the 12-month visit (Engagement)
Percentage of patients who continue to use the tool (Engagement)
Percentage of patients who respond to fall prompts (Adherence)
6 months
Percentage of patient-clinician encounters initially use the tool (Adoption)
Percentage of patients initially use the tool (Adoption)

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

1
Diet Intervention
1
Vancomycin
3
fenebrutinib

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

MS FIT: Falls Insight Track
1 of 1

Experimental Treatment

100 Total Participants · 1 Treatment Group

Primary Treatment: MS FIT: Falls Insight Track · No Placebo Group · N/A

MS FIT: Falls Insight Track
Behavioral
Experimental Group · 1 Intervention: MS FIT: Falls Insight Track · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months

Who is running the clinical trial?

National Library of Medicine (NLM)NIH
36 Previous Clinical Trials
103,746 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,550 Previous Clinical Trials
24,611,045 Total Patients Enrolled
9 Trials studying Multiple Sclerosis
1,245 Patients Enrolled for Multiple Sclerosis
University of California, San FranciscoLead Sponsor
2,346 Previous Clinical Trials
11,782,612 Total Patients Enrolled
22 Trials studying Multiple Sclerosis
2,386 Patients Enrolled for Multiple Sclerosis
Riley Bove, MDPrincipal InvestigatorUniversity of California, San Francisco
6 Previous Clinical Trials
394 Total Patients Enrolled
6 Trials studying Multiple Sclerosis
394 Patients Enrolled for Multiple Sclerosis

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

Is enrollment still open for this clinical research?

"Affirmative. Evidence on clinicaltrials.gov reveals that after first being posted on April 12th 2023, this research study is actively seeking participants. The trial aims to recruit a hundred people from one medical centre." - Anonymous Online Contributor

Unverified Answer

What is the total enrollment of this research endeavor?

"Affirmative. As evidenced by clinicaltrials.gov, this clinical trial is presently recruiting participants and was first posted on April 12th 2023; the data has been refreshed as of April 27th 2023. 100 patients are being accepted across 1 location for the study." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top